Is Unlicensed Medical Cannabis Still Regulated in the UK?

Since the UK’s landmark rescheduling of cannabis-based products for medicinal use in November 2018, questions abound about what "regulated" really means in practice. Despite headlines proclaiming that medical cannabis is now “legal” in the UK, the reality is more nuanced—especially when it comes to unlicensed cannabis medicines and how they are accessed through the NHS versus private clinics.

In this detailed post, we’ll unpack the current regulatory framework governing medical cannabis in the UK, clarify the specialist prescribing rules, and explain why unlicensed cannabis-based medicines remain a complex and cautious area for doctors and patients alike.

We’ll also point you towards helpful resources like medicalcannabis.co.uk for clinic comparisons and releaf.co.uk for accessible explainer guides.

The 2018 Rescheduling: What Changed?

Before November 1, 2018, cannabis and its derivatives were classified under the most restrictive categories in UK drug law—making prescribing for medicinal use virtually impossible. Then came a momentous change:

• Rescheduling: Cannabis-based products for medicinal use were reclassified from Schedule 1 (no recognised medical use) to Schedule 2 controlled substances under the Misuse of Drugs Regulations 2001.
• Legal Prescribing: This allowed specialist doctors to legally prescribe cannabis-based products, including unlicensed medicines, provided they complied with strict regulations.

In simple terms, since late 2018 medical cannabis is legal to prescribe under controlled circumstances. However, this did not mean cannabis became an NHS-funded treatment option widely accessible to all who might benefit.

One Sentence Translation for Patients:

If your doctor is a specialist, they can legally prescribe medical cannabis – but don’t expect it to be available on the NHS anytime soon.

Regulated Medical Cannabis in the UK: What Does It Mean?

“Regulated” in this context means that cannabis-based products intended for medicinal use are misuse of drugs regulations 2001 controlled substances under UK law, and their prescription and use are subject to strict legal frameworks. This includes:

• Licensing: Some cannabis medicines are licensed products with Marketing Authorisation granted by the Medicines and Healthcare products Regulatory Agency (MHRA).
• Unlicensed Use: Many cannabis products used in the UK are unlicensed (also called “specials”) because they do not have full MHRA approval yet.
• Prescribing Controls: Only recognised specialist doctors on the General Medical Council (GMC) specialist register can initiate prescriptions.
• Dispensing Regulations: Pharmacies and dispensers must handle these medicines under controlled conditions with secure storage and record-keeping.

Therefore, “regulated medical cannabis UK” means it’s treated similarly to other controlled medicines, but this does not guarantee https://bizzmarkblog.com/which-conditions-does-the-nhs-actually-fund-medical-cannabis-for/ availability or NHS funding.

Specialist-Only Prescribing Rules in the UK

One critical element post-2018 is that only specialists—consultants or doctors on the GMC specialist register—can prescribe medical cannabis products. General Practitioners (GPs) are not permitted to initiate prescriptions.

This restriction aims to ensure that prescribing decisions are made by doctors with the highest expertise in the patient's condition and cannabis medicine. However, it also means access is restricted and patients often turn to private clinics.

Example of Specialist Prescribing in Practice:

• A patient with treatment-resistant epilepsy might be referred to a neurologist trained in medical cannabis prescribing.
• That neurologist, as a specialist, can then prescribe a cannabis-based medicine if clinically appropriate.
• However, the GP generally cannot start or continue the prescription without specialist involvement.

For patients researching private medical cannabis clinics, tools like medicalcannabis.co.uk provide directories and comparisons to find specialists operating in this field.

Unlicensed Cannabis Medicine: The NHS Perspective and Caution

The NHS remains cautious about prescribing medical cannabis, particularly unlicensed cannabis-based medicines. This caution reflects several factors:

• Limited Large-Scale Clinical Trial Evidence: Many products have less robust clinical trial data compared to licensed medicines.
• NHS Funding Constraints: NHS England has set stringent criteria and made funding exceptions in only a few clinical scenarios (e.g., severe epilepsy in children).
• Medicolegal Precautions: Prescribers worry about liability prescribing unlicensed medicines with less clear efficacy evidence.
• Variation in Product Quality and Composition: Unlicensed products may vary in cannabinoid ratios and contain trace substances not consistently present across batches.

Despite this, unlicensed cannabis medicines remain legally prescribable under specialist guidance, often via “specials” routes where licensed equivalents aren’t yet available. This leads many patients to seek private prescriptions where the specialist can judge the potential benefit on an individual basis.

NHS Funding vs Legal Prescribing

Aspect Legal Prescribing NHS Funding Legality Permitted since 2018 for specialists under strict controls NHS funding decision is separate from legality Who Can Prescribe Specialists only (consultants or GMC registered specialists) Same prescribers, but only specific indications approved Cost to Patient Private prescriptions require patient payment (varies by clinic) NHS-funded prescriptions free at point of care Access Private clinics and some NHS hospitals (rare) Very limited to select clinical indications (e.g., epilepsy)

Note: As of the time of writing, no specific prices for private medical cannabis prescriptions were stated in publicly available sources. Should future recommendations or sources include exact price points, we will quote them with proper attribution.

Important Tools and Resources for Patients Exploring Medical Cannabis

• medicalcannabis.co.uk: A UK-focused directory and comparison site helping patients to explore private clinics specialising in medical cannabis prescribing, including patient reviews and pricing transparency.
• releaf.co.uk: An accessible explainer resource providing guidance on how medical cannabis works, what regulations mean for patients, and navigating the complexities of NHS vs private access.

In Summary: Yes, But With Caveats

Medical cannabis in the UK is regulated in the sense that it is a controlled medicine legally prescribable by qualified specialists under strict rules since 2018. However, “regulated” does not mean easy to access:

1. Most cannabis-based medicines remain unlicensed specials, treated cautiously by the NHS.
2. NHS funding is limited to very specific indications and exceptional cases, not general access.
3. Only specialist doctors—never GPs—can prescribe medical cannabis for patients in the UK.
4. Many patients turn to private clinics, with associated costs and variable prices.

For patients considering medical cannabis, it’s vital to understand legal prescribing is different from funding or NHS coverage. Use trusted resources, ask to be referred to specialist consultants where appropriate, and scrutinise any marketing claims closely.

Medical cannabis is regulated in UK law, but access remains tightly controlled and governed by specialist judgement, clinical evidence, and funding decisions—so don’t be misled into thinking “legal” means universally available or routinely prescribed on the NHS.